Stryker Corp. (NYSE: SYK ) spent more than 58 percent of its cash reserves during the first quarter on its $1.45 billion buyout of Boston Scientific’s (NYSE:BSX) neurovascular business.
Mergers & Acquisitions
Johnson & Johnson CFO: Synthes deal doesn’t mean we’re done
Johnson & Johnson (NYSE:JNJ) may have just dropped a cool $21.3 billion to acquire Synthes (SWX:SYST.VX), but it doesn’t mean the health products giant is done shopping for deals.
“Although we just did a pretty significant deal, it doesn’t preclude us from doing another one,,” CFO Dominic Caruso told an investor’s conference in Boston. “We want to be able to act.”
GE Healthcare snaps up cellular imaging firm | Acquisitions roundup
GE Healthcare is looking to boost its life sciences portfolio with the acquisition of a cellular imaging firm.
The General Electric Co. (NYSE:GE) unit is planning to buy Seattle area Applied Precision Inc. in a bid to expand its research products and services offering for the pharmaceutical and life science industries, the company said.
Synthes stays flat, Johnson and Johnson ticks down on $21 billion buyout
ev3 pays off big for Covidien
The flurry of moves Covidien plc (NYSE:COV) made in 2010 are starting to pay off for the Mansfield, Mass.-based medical products conglomerate.
New business from its $2.6 billion ev3 acquisition helped Covidien double its vascular unit’s sales during the three months ended March 25, posting revenues of $333 million, up 103 percent over the same period last year. And Covidien saw strong increases in sales of energy devices from the $250 million Somanetics buyout it consummated last July. That division reported a 17 percent increase over Q2 2010.
Synthes takeover could be the orthopedics makeover that Johnson & Johnson needs
MASSDEVICE ON CALL — Johnson & Johnson’s (NYSE:JNJ) may be looking at its proposed mega-merger with Synthes as a way to save its orthopedics business.
GE Healthcare acquires high tech MRI company | Acquisitions roundup
GE Healthcare added another MRI technology to its imaging portfolio with the acquisition of Minneapolis-based Steady State Imaging.
SSI’s imaging platform is based on the University of Minnesota-developed SWIFT (Sweep Imaging with Fourier Transformation) method, which gives radiologists the ability to see tendons, ligaments and other tissues, an imaging capability not available in conventional imaging methods, according to GE Healthcare.
Report: Johnson and Johnson in talks to buy Synthes for $20 billion
Johnson & Johnson (NYSE:JNJ) is in talks to buy Synthes Inc. for $20 billion, according to a report in the Wall Street Journal.
Clinical Research firm Trio rebrands, changes strategy after merger
The North Carolina CRO that launched as Trio Clinical Research is moving forward with a new name and a different strategy.
Trio changed its official name to Trio Clinical Resourcing, a change that reflects the Raleigh, N.C.-based CRO’s focus on providing recruiting and staffing services to biotechnology, pharmaceutical and medical device companies, according to Trio.
Endo targets American Medical Systems for $2.9 billion | Acquisitions roundup
A company that began life in the pharmaceutical sector is venturing forth into devices in its quest to become a more diversified health care company.
Alcon shareholders submit to Novartis
Alcon Inc. (NYSE:ACL) shareholders approved a final acquisition by Novartis AG (NYSE:NVS) at their annual meeting.
Under the terms of the takeover deal, Alcon shareholders will receive 2.9228 Novartis shares and a cash payment of $8.20 for each Alcon share, according to Alcon.
Based on NVS shares’ $55.60 latest closing price, the exchange represents a 1.4 percent premium over ACL shares’ closing price of $168.34 yesterday.